| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $12.10 ▼ -0.69% | Yesterday | $12.22 ▲ +0.29% | Tomorrow's Elicio Therapeutics Inc. Common Stock (ELTX) setup is anchored to $12.18 and targets $12.10 (-0.69%). The near-term read is downside; watch $12.55 / $11.81 because daily realized volatility is about 3.57%. |
Tomorrow's Elicio Therapeutics Inc. Common Stock (ELTX) setup is anchored to $12.18 and targets $12.10 (-0.69%). The near-term read is downside; watch $12.55 / $11.81 because daily realized volatility is about 3.57%. | ||||
| Week | $11.92 ▼ -2.16% | Last Week | $12.29 ▲ +0.91% | The 7-day Elicio Therapeutics Inc. Common Stock model moves from $12.29 to $11.92 (-2.16%). It gives downside momentum context for this stock, so breaks around $12.55 / $11.81 matter more than a single tick. |
The 7-day Elicio Therapeutics Inc. Common Stock model moves from $12.29 to $11.92 (-2.16%). It gives downside momentum context for this stock, so breaks around $12.55 / $11.81 matter more than a single tick. | ||||
| Month | $11.62 ▼ -4.59% | Last Month | $12.41 ▲ +1.93% | The 1-month Elicio Therapeutics Inc. Common Stock target is $11.62 (-4.59%), compared with the live reference near $12.18. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Elicio Therapeutics Inc. Common Stock target is $11.62 (-4.59%), compared with the live reference near $12.18. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $11.18 ▼ -8.24% | Last Year | $12.60 ▲ +3.46% | The 1-year Elicio Therapeutics Inc. Common Stock scenario points to $11.18 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Elicio Therapeutics Inc. Common Stock scenario points to $11.18 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $10.13 ▼ -16.80% | 5 Years Ago | $13.04 ▲ +7.06% | The 5-year Elicio Therapeutics Inc. Common Stock view is $10.13 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Elicio Therapeutics Inc. Common Stock view is $10.13 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $12.18 | Mid |
| Daily Change | -0.16% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 57% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $12.18 | Daily Change | -0.16% |
| Market Cap | $224.06M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.